Stotles logo
Awarded

CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins

Published

Supplier(s)

Dr.Reddy's Laboratories (UK) Limited, Pfizer Ltd, TECHDOW PHARMA ENGLAND LIMITED, Aventis Pharma ltd t/a Sanofi, Tetris Pharma Ltd, Mylan, ROVI BIOTECH LIMITED, LEO Pharma

Value

186,609,000 GBP

Description

NHS National Framework for low molecular weight heparin products and fondaparinux Offer reference number: CM/PHR/22/5687 Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Timeline

Publish date

a year ago

Award date

a year ago

Buyer information

NHS England

Contact:
Katie Noonan
Email:
katie.noonan@nhs.net

Explore contracts and tenders relating to NHS England

Go to buyer profile
To save this opportunity, sign up to Stotles for free.
Save in app
  • Looking glass on top of a file iconTender tracking

    Access a feed of government opportunities tailored to you, in one view. Receive email alerts and integrate with your CRM to stay up-to-date.

  • ID card iconProactive prospecting

    Get ahead of competitors by reaching out to key decision-makers within buying organisations directly.

  • Open folder icon360° account briefings

    Create in-depth briefings on buyer organisations based on their historical & upcoming procurement activity.

  • Teamwork iconCollaboration tools

    Streamline sales workflows with team collaboration and communication features, and integrate with your favourite sales tools.

Stop chasing tenders, start getting ahead.

Create your free feed

Explore similar tenders and contracts

Browse open tenders, recent contract awards and upcoming contract expiries that match similar CPV codes.

Explore other contracts published by NHS England

Explore more open tenders, recent contract awards and upcoming contract expiries published by NHS England.

Explore more suppliers to NHS England

Sign up